Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Hayden

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Tissue Antigens|January 1, 1996
Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragmentsL K Gilliland, N A Norris, H Marquardt, et al.
Therapeutic Immunology|January 1, 1994
Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression systemM S Hayden, P S Linsley, M A Gayle, et al.
Tissue Antigens|October 1, 1996
Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigenM S Hayden, L S Grosmaire, N A Norris, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Tissue Antigens|January 1, 1996
Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragmentsL K Gilliland, N A Norris, H Marquardt, et al.
Therapeutic Immunology|January 1, 1994
Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression systemM S Hayden, P S Linsley, M A Gayle, et al.
Tissue Antigens|October 1, 1996
Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigenM S Hayden, L S Grosmaire, N A Norris, et al.
Pageof 2